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Lymphatic vessels are essential for tissue homeo-
stasis and immune surveillance and contribute to
pathological conditions. Lymphatic endothelium
differentiates from veins and forms an indepen-
dent vascular tree with only few connections to the
venous circulation. Failure of blood and lymphatic
vessel separation results in hemorrhage and edema.
VEGF-C and -D are strong inducers of lymphangio-
genesis and have essential (VEGF-C) and modulatory
(VEGF-D) roles during developmental lymphangio-
genesis. We describe here a myeloid population
that is defined by expression of the tyrosine kinase
Syk, comprises largely M2-polarized mononuclear
cells, and robustly expresses angiogenic factors,
including VEGF-C/-D and chemokines. These cells
stimulate lymphangiogenesis in vivo. Deletion of
Syk causes increased chemotractant production,
enhanced transmigration, and accumulation in the
skin. Ensuing lymphatic hyperplasia and vessel dila-
tion cause the formation of blood-lymphatic shunts.
This mechanism does not involve circulating endo-
thelial progenitor cells and demonstrates the poten-
tial of hematopoietic cells to control developmental
lymphangiogenesis.
INTRODUCTION
Coordinated function of blood and lymph vessels is indispens-
able for tissue homeostasis. Blood vessels transport cells,
oxygen, nutrients, and signals and remove waste products and
metabolites. Lymphatic vessels absorb excess interstitial fluid
and proteins and partake in the immune surveillance and dietary
fat resorption. Lymphatics also contribute to pathological con-
ditions like chronic inflammation, tumor spread, and lymphe-
dema (Alitalo et al., 2005; Cueni and Detmar, 2006).
To ensure efficient tissue drainage and immune protection,
lymph vessels cover the entire body and, with the exception of
two connections to the venous circulation, are strictly separateDevelofrom blood vessels. The importance of blood-lymphatic separa-
tion is highlighted by a number of mouse mutants that develop
aberrant connections (Abtahian et al., 2003; Backhed et al.,
2007; Ichise et al., 2009; Makinen et al., 2005; Fu et al., 2008;
Taniguchi et al., 2007; Johnson et al., 2008). These often-lethal
malformations, which arise during embryogenesis, but also
postnatally, suggest that active mechanisms ensure the sepa-
ration of blood and lymph vessels throughout life. How blood-
lymphatic separation is maintained, however, remains unclear.
Previous studies implicated migration defects in bone marrow-
derived circulating lymphatic endothelial progenitor cells
(Sebzda et al., 2006). In addition to endothelial cell-autonomous
mechanisms hematopoietic defects were discussed (Abtahian
et al., 2003).
During development, blood vessel formation precedes the
differentiation of lymphatic endothelial cells (LECs), which
develop from the venous branch of the circulation (Oliver,
2004). After delamination from venous vessels, LECs form
primary lymph sacs, which, via sprouting lymphangiogenesis,
reorganize into an independent lymphatic vascular tree (Adams
and Alitalo, 2007). Lymphangiogenesis strongly relies on para-
crine control by the vascular endothelial growth factor-C
(VEGF-C). VEGF-C/ endothelial cells commit to the lymphatic
lineage, but remain confined to their venous origin and fail to
organize into lymph sacs (Karkkainen et al., 2004). VEGF-C
and the related VEGF family member VEFG-D both efficiently
induce the growth of cutaneous lymphatic vessels in transgenic
mice. VEGF-C and -D are the only known ligands for the vascular
endothelial growth factor receptor-3 (VEGFR-3), which in the
adult is restricted to LECs (Kukk et al., 1996; Veikkola et al.,
2001).
VEGF-D appears to be dispensable for lymphatic develop-
ment, as its loss does not impair lymph vessel development
(Baldwin et al., 2005) and combined deletion of VEGF-C and
-D is largely equivalent to VEGF-C deficiency (Haiko et al.,
2008). However, gene silencing of VEGF-D in combination with
other lymphangiogenic factors in Xenopus tadpoles identified
VEGF-D as a modifier of lymphangiogenesis (Ny et al., 2008).
VEGF-C is produced by vascular smooth muscle cells and
mesenchymal cells close to the migratory destination of lym-
phatic progenitors (Kukk et al., 1996; Karkkainen et al., 2004).
VEGF-D is produced in a dynamic pattern most prominently by
the lung, kidney, and mesenchymal cells of the skin (Avantag-
giato et al., 1998; Achen et al., 2001). In adult mice, myeloid cells,pmental Cell 18, 437–449, March 16, 2010 ª2010 Elsevier Inc. 437
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like inflammation and tumors, have been identified as sources
of VEGF-C and -D (Baluk et al., 2005; Cursiefen et al., 2004;
Machnik et al., 2009).
The influence of other growth factor families on lymphangio-
genesis is less well investigated. Angiopoietin 1 (Ang1) can
directly stimulate lymphatic growth and sprouting by regulation
of VEGFR-3 (Tammela et al., 2005; Morisada et al., 2005). Angio-
poitin 2 (Ang2) deficiency results in abnormally patterned, leaky
lymphatics (Gale et al., 2002). Ang2 appears to prevent prema-
ture maturation of initial lymphatics and thereby regulates the
thickness of the lymphatic plexus in the skin (Dellinger et al.,
2008). Finally, Eph receptors and their membrane-bound ligands
(ephrins) signal the postnatal remodelling of lymphatic vessels
(Makinen et al., 2005).
The cytoplasmic tyrosine kinase Syk is widely expressed in
hematopoietic cells and has been implicated in a variety of
hematopoietic cell responses, including immunoreceptor and
integrin signaling (Turner et al., 2000). Syk is characterized by
two N-terminal SH2 domains that bind in tandem to closely
spaced p-Tyr residues within the immunoreceptor tyrosine-
based activation motifs (ITAMs) of immunoreceptor intracellular
signaling chains (Latour and Veillette, 2001).
Mice deficient for the nonreceptor tyrosine kinase Syk (Syk/)
die at midgestation due to blood-lymphatic shunts (Abtahian
et al., 2003; Kiefer et al., 1998; Sebzda et al., 2006), and less
than 1% of Syk/ embryos survive midgestation.
In this study, we used genetic fate mapping to identify the
cell compartment responsible for the vascular alterations caused
by Syk deficiency. We did not detect Syk expression in lymphatic
endothelium; however, we identified Syk-expressing myeloid
cells, which produced chemokines and growth factors, including
VEGF-C/-D. This Syk-expressing myeloid population was largely
comprised of M2-polarized monocytes. Upon transplantation
into a dorsal skin fold chamber, these cells displayed a strong
lymphangiogenic activity that was abrogated by VEGF-C/-D
sequestration and demonstrated their potential to direct lym-
phangiogenesis. Loss of Syk resulted in elevated VEGF-C/-D
production and a strong upregulation of the M1 chemokine
CCL2 and its corresponding receptor CCR2. In Syk/ embryos,
this resulted in an accumulation of these factors in the skin and
massive lymphatic hyperplasia.RESULTS
Aberrant Vascular Morphogenesis and Lymphatic
Hyperproliferation Characterize the Vessels in the Skin
of Syk/ Embryos
Syk/ embryos die at midgestation from fatal blood-lymphatic
malformations. We therefore reasoned that Syk-expressing cells
are crucial for the regulation of lymphatic growth. To precisely
analyze the defects caused by Syk deficiency, we investigated
the skin vasculature of Syk/ embryos and rare surviving
neonates. Consecutive confocal sections of whole-mount skin
preparations from wild-type fetuses at day 14.5 of development
or neonates revealed a clear spatial separation of the developing
blood and lymphatic capillaries (Figures 1A and 1B). In contrast,
we noted a lymphatic hyperplasia in Syk/ skins. Frequently,438 Developmental Cell 18, 437–449, March 16, 2010 ª2010 Elsevierblood vessels appeared to be ensheathed by lymphatic endo-
thelium (Figure 1B, arrow heads). In support of a lymphatic
hyperproliferation, the Lyve-1/PECAM1 double-positive cell
population was 3-fold increased in disaggregated skin prepara-
tions (Figure 1C). Determination of skin vessel diameters at
embryonic day (E13.5) revealed a dilation of both blood (179%
of average diameter) and lymphatic vessels (194% of average
diameter) in Syk/ samples (Figures 1D and 1E). Indeed, we de-
tected blood vessel malformations in Syk/ embryos preceding
lymph vessel development (Figure S1 available online).
Grossly distended Lyve-1+ lymphatics also stained positive for
the lymphatic-specific homeobox transcription factor Prox-1
(Wigle and Oliver, 1999) (Figure 2A). The lymphatic hyperplasia
in Syk/ skin caused a convergence of blood and lymphatic
vessels, which were well separated in wild-type skin. Tomato
lectin injected into the vitelline vein of E14.5 Syk/ fetuses
was found to have access to selected Prox-1+ skin lymph
vessels (Figure 2B). We did not observe staining of lymph vessels
in the skin of wild-type or E13.5 Syk/ embryos. PECAM1 im-
munostaining of Syk/ fetuses revealed direct contact forma-
tion between blood endothelial cells (BECs) and LECs, which
was not observed in wild-type controls (Movie S1). In Syk/
skin, overgrowing lymphatic endothelium appeared to wrap
around blood vessels (Figures 1B, 2D, and 2E), resulting in the
immediate juxtaposition of BECs and LECs. These findings, sup-
ported by three-dimensional (3D) reconstructions of confocal
image stacks (Movie S2), suggested that the development of
contacts between blood and lymph vessels formed at sites of
close approximation of both vessel types caused by lymphatic
hyperplasia.
A Mouse Model for Genetic Tracing of Syk-Expressing
Cells during Development
We wanted to unequivocally identify the cells that express Syk
and likely cause vascular malformations during mouse develop-
ment. Therefore, we generated ‘‘knockin’’ mice that express Cre
recombinase under control of the endogenous Syk promoter
(Syk-Cre) and allowed us to trace Syk promotor activity. Insertion
of Cre rendered the Syk gene nonfunctional. Homozygous Syk-
Cre embryos faithfully phenocopied the published Syk knockout
(Cheng et al., 1995; Turner et al., 1995) (Figure 3A) and will there-
fore also be referred to as KO (for knockout) in this manuscript.
Heterozygotes, referred to as KI (for knockin), were indistinguish-
able from wild-type and expressed approximately half as much
Syk protein as wild-types (Figure 3B). A Pgk-neo cassette,
present in the Syk-Creneo driver allele, was removed by FLPe-
mediated recombination, resulting in the Syk-CreD allele (Fig-
ure 3C). After crossing with R26R-lacZ reporter mice (Soriano,
1999), Syk-Creneo/+//R26R-lacZ/+ embryos first displayed lacZ
activity at E10.5 in the lower branchial arch region (arrow head)
and the fetal liver primordium (arrow) (Figure 3D). At E12.5, fetal
liver, developing thymus, and derivatives of the lower branchial
arches stained strongly. LacZ staining of reporter allele-homozy-
gous mice was always superior to staining in heterozygotes
(Figure 3E). We extensively tested the sensitivity of our fate
mapping model. Bone marrow-derived myeloid colonies of
Syk-Creneo/+//R26R-lacZ/+ mice cultured in semisolid medium
stained more than 85% completely blue. Staining was indepen-
dent of the colonies being comprised of a single or multipleInc.
Figure 1. Aberrant Vascular Morphogenesis Char-
acterized by Lymphatic Hyperproliferation and
Blood-Lymphatic Mixing in Syk/ Embryos
(A and B) Skin whole-mount preparations of (A) neonates
or (B) embryos at E14.5 were immunostained for endomu-
cin (red) and Lyve-1 (green). Central square, projection of
a 40 or 50 mm confocal Z stack; flanking rectangles (yellow
and red edges), orthogonal sections; square beneath (blue
edge), selected Z planes of the projection. Respective
sectional planes are indicated by yellow, red, and blue
lines. Numbers represent the thickness of the stacks/
planes in micrometers. Scale bars represent 50 mm. For
schematic layout, see Figure S1.
(C) Skin was dissected, disaggregated, immunostained for
Lyve-1 and PECAM-1, and analyzed by flow cytometry.
The Lyve-1+/PECAM-1+ population includes all LECs.
Bars depict fold excess of the respective population in
Syk/ skins over wild-type (average of two experiments).
(D and E) (D) Blood and (E) lymphatic vessels were immu-
nostained in skin whole mounts from Syk/ (open bars)
and control (black bars) embryos at E13.5, three different
embryos each. In five nonoverlapping view fields for each
embryo, the diameter of blood and lymph vessels in
comparable dermal layers was measured. Bars indicate
numbers of vessels in five different caliber classes.
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R26R-YFP reporter line (Srinivas et al., 2001), we were able to
demonstrate Syk promoter activity in >95% of CD19+ spleenic
B cells and >90% of CD33-positive T cells from peripheral
lymph nodes, provided the animals were homozygous for the
reporter allele (Figures S2B–S2E). Our fate mapping approach
labeled Syk-expressing cells with high efficacy, but also faithfully
detected transient Syk expression as in developing T cells (Pal-
acios and Weiss, 2007). We therefore concluded that Syk-CreD
mice allow for the detection of all Syk-expressing lineages during
development.
Fate Mapping Provides No Evidence for Endothelial Syk
Expression; However, Syk Deficiency Results
in an Accumulation of Myeloid Cells in the Skin
To identify all Syk-expressing cells in the developing skin, we
immunostained whole-mount preparations of Syk-CreD //R26R-
YFP embryos ranging from E12.5 to E16.5 for yellow fluorescent
protein (YFP) and blood or lymphatic markers. In more than 30
whole-mount preparations analyzed, we detected not a singleDevelopmental Cell 18, 4instance of blood or lymphatic endothelial YFP
expression (Figures 4A–4C). We did note,
however, a prominent accumulation of isolated,
YFP-expressing (YFP+) cells. To probe for a
possible hematopoietic nature, YFP+ cells were
stained for CD45, which marked 70% of the
YFP+ cells (Figures 5A and 5B; Figure S4).
To exclude a general myeloproliferation, we
compared fetal liver weight and cellularity
between Syk/ and wild-type embryos. We
detected no difference at E12.5; however, start-
ing at E13.5, fetal liver development in Syk/
embryos was persistently reduced compared
to wild-type littermates (Figures S3A and S3B).Despite the reduced leukocyte cellularity and a concomitant
reduction in clonogenic progenitor (colony forming cell [CFC])
frequency (Figure S3C), YFP+ cell numbers in the skin of Syk/
embryos were persistently increased (Figure 4; Figure S3D).
YFP+ cells isolated from skin failed to divide in semisolid medium
(data not shown), indicative of mature, differentiated myeloid
cells. Morphologically, they resembled monocytes or macro-
phages in May-Gru¨nwald-Giemsa staining (Figures 5C–5E).
Taken together, our fate mapping of Syk-expressing cells
excludes an endothelial cell-autonomous defect and demon-
strates an accumulation of mature myeloid cells in the proximity
of developing skin vessels.
A Large Fraction of the YFP+ Myeloid Population
Expresses Markers Characteristic of M2-Polarized
TEMs
We further characterized the Syk-expressing YFP+ myeloid pop-
ulation from skin by using flow cytometry. At E13.0, 75% of the
YFP+ cells expressed CD11b and CD45. Interestingly, the Tie-2+
fraction was only marginally smaller (Figure 5A), suggesting that37–449, March 16, 2010 ª2010 Elsevier Inc. 439
Figure 2. Lymphatic Hyperplasia in Syk/
Embryos Intimately Juxtaposes Blood and
Lymph Vessels
(A–C) Skin whole-mount preparations (A) immuno-
stained for Prox-1 (red), Lyve-1 (green), and isolec-
tin B4 (blue); (B) after injection of FITC-labeled
tomato lectin (green) via the vitellin vein and immu-
nostaining for Prox-1 (red); or (C) immunostained
for Prox-1 (green) and PECAM-1 (red). (B) Arrows
denote lectin-stained LECs, indicative of direct
blood-lymphatic connections, inset: overview
projection. (C) Note the weak PECAM-1 staining
of oak leaf-shaped Prox-1+ LECs (arrowheads)
and the formation of blood-lymph endothelial cell
contacts (arrows). Scale bars represent 50 mm,
and numbers represent the thickness of projection
in micrometers.
(D) In wild-type embryos, blood and lymph vessels
are spatially well separated. In Syk/ embryos,
due to lymph hyperplasia, blood vessels are over-
grown by lymphatics (red arrows indicate points of
direct contact).
(E) Typical appearance of a section (see Figure 1B)
at the indicated plane (black line).
(F) Lateral view of a Z stack from a Syk/ embryo.
Arrowheads indicate erythrocytes in distended
lymph vessel (green), and the arrow indicates
a blood vessel (red) in direct contact with LECs.
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expressing monocytes (TEMs). The expression profile at E14.5
was strikingly similar; 75% of the YFP+ cells expressed CD31
and CD45. Approximately 50% (KI) or 75% (KO) were positive
for Tie-2 and F4/80 (Figure 5B), whereas YFP+, Ly6G+ granulo-
cytes comprised less than 20%. Significantly lower percentages
of marker positive cells in fetal liver are likely due to the presence
of more immature cells (Figures 5A and 5B; Figure S4).
With the exception of Gr-1, which in macrophages from adult
mice is restricted to inflammatory M1-polarized cells, the marker
profile of YFP+ skin cells is distinctly more compatible with
M2-polarized TEMs than inflammatory macrophages (Pucci
et al., 2009; Mantovani et al., 2004). It has to be pointed out
that, despite the rather similar marker profile of YFP+ KI and
KO cells, YFP+ KO cells in the skin are about three times more
abundant. Morphologically, FACS-sorted YFP+ cells from KI
skin appeared as a homogeneous population with typical mono-
cyte/macrophage appearance (Figures 5C, 5E, and 5F), whereas440 Developmental Cell 18, 437–449, March 16, 2010 ª2010 Elsevier Inc.KO skin cells were more heterogeneous,
with an increased fraction of larger cells
with numerous vacuoles (Figures 5D–
5F). The cell morphology corroborated
the conclusion that YFP+ skin cells are
largely comprised of monocytes/macro-
phages.
To test if these cells could be respon-
sible for the lymphatic hyperproliferation
observed in Syk/ skin, we incubated
cytodex beads, which were coated with
VEGFR-2 and -3-expressing mouse
endothelial cells, with the YFP+ cells iso-
lated from one E14.5 skin (KI: 20,000 cells, KO: 60,000 cells)
or 60,000 cells from fetal liver. After 48 (Figure 5G) or 72 hr
(Figure 5H), we determined the number and length of the endo-
thelial sprouts on 35 randomly selected beads. Both parameters
were enhanced upon incubation with KO skin cells. YFP+ cells
from KI skin produced only a small response, whereas fetal
liver-derived cells were practically ineffective.
Syk-Expressing Myeloid Cells Produce Chemokines
and Lymph-Angiogenic Growth Factors
in the Developing Skin
To obtain mechanistic insight into the action of the Syk-express-
ing myeloid population, we characterized skin extracts through
a panel of 58 multiplexed immunoassays (RBM, Austin, Texas,
USA). Particularly striking was the up to five-fold accumulation
of the closely related chemokines MCP-1/CCL2 and MCP-5/
CCL12 that paralleled the development of vascular defects
in KO skin (Figure 6A). Isolated Syk/, YFP+ fetal liver cells
Figure 3. In Vivo Tracing of Syk Promoter Activity
(A) Heterozygous Syk-Creneo orSyk-CreD fetuses were pheno-
typically wild-type, whereas homozygotes phenocopied the
Syk deletion.
(B) Syk protein expression in fetal liver of wild-type, heterozy-
gous, or homozygous Syk-CreD fetuses.
(C) Using homologous recombination in ES cells, Cre recom-
binase was expressed under control of the mouse Syk
promoter, resulting in the Syk-Creneo allele. Removal of the
Pgk-neo cassette by crossing with FLPe resulted in the Syk-
CreD allele.
(D and E) (D) Syk-Creneo and (E) Syk-CreD mice were crossed
with the R26R-lacZ reporter strain, embryos were recovered
at the (D) indicated developmental stages or at (E) E13.5,
and Syk promoter activity was visualized by whole-mount
lacZ staining. Respective genotypes are indicated. The arrow-
head indicates the lower branchial arch region, the arrows
indicate fetal liver, and the asterisk indicates the perineural
vascular plexus. The inset shows the control harboring only
the reporter allele (see also Figure S2).
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MCP-3, but were positive for myeloperoxidase, as were YFP+
skin cells, which we identified as the source of the elevated
MCP-1 levels (Figure 6B). To further characterize the YFP+
population, we tested RNA expression of 35 candidate genes
implicated in angiogenic processes. We present here expression
data on 14 genes, which we found to be consistently altered by
quantitative reverse transcriptase (RT)-PCR.
Although fetal liver cells from wild-type and KO samples were
similar (Figure 6C), message levels for angiopoietins (Ang1 and
Ang2), FGF2, Jagged-1, MMP-2, MPO, VEGF-C, and VEGF-D
were elevated in KO skin compared to wild-type or KI skin
(Figure 6D). To identify mRNAs, which were directly altered in
YFP+ cells, we analyzed FACS-sorted YFP+ cells. Again, differ-
ences between KO and KI fetal liver were small (Figure 6E).
In sharp contrast, YFP+ cells from KO skin expressed increased
levels of EphB4, MCP-1, Timp-1, and VEGF-D, and to a lower
degree VEGF-C, compared to KI skin (Figure 6F). Ang2 was
not expressed in YFP+ myeloid cells. Compared to fetal liver,
YFP+ cells from skin revealed a characteristic expression pattern
of factors active in angiogenic processes (EphB4, FGF-2,
MCP-1, MMP-2, MMP-9, PDGF-B, Timp-1, VEGF-C, andDevelopmental Cell 1VEGF-D) (Figure 6G). Importantly, these factors
were even more strongly expressed in YFP+ cells
from KO skin (Figure 6H). Interestingly, we only
detected upregulation of the CCL2 receptor
CCR-2 in YFP+ cells from KO skin (Figure 6I).
Taken together, our analysis suggested that
Syk expression defines an angiogenically active
myeloid population in the skin, which is largely
comprised of M2-polarized TEMs. Loss of Syk
results in a strong upregulation of VEGF-D and
the inflammatory M1 chemokine CCL2 and its cor-
responding receptor CCR-2.
We wondered if the accumulation of chemotrac-
tants in KO skin caused an increased immigration
of fetal liver cells. We therefore tested the migration
of either KI or KO fetal liver cells through a mono-layer of bEnd5 endothelioma cells toward cell free lysates from
KI or KO skins. We observed that the genotype of the fetal liver
cells was irrelevant; however, the presence of KO skin lysate
caused a three-fold increase in migration compared to KI lysate
(Figure 6K).
MyeloidCells Identified by SykPromoter Activity Display
an Angiogenic Activity in an ‘‘In Vivo’’ Grafting Model
VEGF-C and -D are potent stimulators of lymphangiogenesis, for
which signaling through VEGFR-3 is sufficient (Veikkola et al.,
2001; Lohela et al., 2008; Enholm et al., 2001). To exclude effects
caused by the accumulation of YFP+ cells in KO fetuses and
directly address their biological potential, we transplanted
a constant number of 100,000 sorted YFP+ cells of different
origin into a dorsal skin chamber. The dorsal skin fold model
offers the benefit of defined, reproducible transplant application
and monitoring for and exclusion of induced inflammation (Lehr
et al., 1993). After 7 days, we confirmed the persistence of the
transplanted cells (Figure S5) and analyzed vascular alterations
by immunostaining. Mice that had received 100,000 YFP+
cells from KO fetal liver, displayed no discernible alterations
compared to controls, which had received a cell-free sham8, 437–449, March 16, 2010 ª2010 Elsevier Inc. 441
Figure 4. Vascular Malformations of the Skin Are Associated with
Massive Leukocyte Accumulations
(A–C) Whole-mount preparations of embryos at (A) E12.5 and (B) E15.5 were
stained for (C) YFP and blood vessels (endomucin or isolectin B4), or YFP
and lymph vessels (Lyve-1). Skin samples were homozygous for the reporter
allele R26R-YFP and heterozygous (top row) or homozygous (bottom row)
for Syk-CreD. Arrows indicate Lyve-1/YFP double-positive cells that are not
incorporated in lymphatic vessels, likely macrophages. Projections of confocal
Z stacks (30 mm) are shown. Scale bars represent 50 mm (see also Figure S3).
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caliber, blind ending vessels (Figure 7A). In contrast, lymphatics
of mice that had been transplanted with KO or KI skin-derived
YFP+ cells were strongly activated, as indicated by an irregular
surface (Figures 7B and 7C) and the extension of filopodia
(Figures 7G and 7H) (Tammela et al., 2005). Comparable lym-
phangiogenic activity was observed in mice that had received
a cell-free dose of recombinant rVEGF-C (Figure 7D and 7I).
The skin chamber data therefore demonstrate the lymphangio-
genic potential of YFP+ myeloid, skin-derived cells also from
Syk-expressing, phenotypically unaffected fetuses. When we,442 Developmental Cell 18, 437–449, March 16, 2010 ª2010 Elsevierhowever, transplanted only 70,000 YFP+ cells from KI or KO
skin, we detected a significant difference in the capacity of this
cell dose to induce an increase in lymphatic vessel area density
or sprouting (Figure 7K), emphasizing the importance of myeloid
cell accumulation in Syk/ skin.Lymphangiogenic Activity of Syk-Expressing Myeloid
Cells Is Suppressed by VEGF-C/-D Sequestration
We wondered if the lymphangiogenic activity of Syk-expressing
myeloid cells was dominated by their VEGF-C/-D expression
and therefore neutralized both growth factors by administration
of soluble VEGFR-3, which effectively binds VEGF-C and -D
and thereby inhibits signaling through the endogenous receptor
(Makinen et al., 2001). Development of lymphatic sprouts and
hence the activation of lymphatic vessels was completely sup-
pressed when skin-derived KI or KO YFP+ cells were cotrans-
planted with 10 mg recombinant VEGFR-3/Fc protein (Figures
7E, 7F, and 7K). Concomitant with lymph vessel activation, we
noted an increase in lymphatic vessel caliber upon transplanta-
tion of YFP+ skin cells, which was also completely reversed by
coadministration of recombinant VEGFR-3/Fc fusion protein
(Figure 7K).
Using transplantation into a dorsal skin chamber, we provided
compelling evidence that mature, myeloid, Syk-expressing cells,
derived from the skin of midgestation mice, are able to direct
lymphangiogenesis. This capacity is dominated by and depen-
dent on the production of VEGF-C and/or -D.DISCUSSION
Here, we investigated developmental defects in the regulation of
lymphatic proliferation and vessel growth in the skin of wild-type
and Syk/ midgestation embryos. Syk deficiency causes strong
lymphatic malformations, including blood-lymphatic shunts or
mixed blood-lymphatic vessels. To identify the responsible
cell compartment, we took a genetic fate mapping approach.
Assuming that Syk-expressing, circulating endothelial progeni-
tors contribute to lymphangiogenesis, migratory defects have
been proposed to be the course of blood-lymphatic shunt
formation (Sebzda et al., 2006). Extensive quality testing demon-
strated that our fate mapping was efficient and sensitive, and
that it detected even transient developmental Syk expression.
The complete absence of genetically marked cells from blood-
vessel and lymphatic endothelium indicated that a contribution
of Syk-expressing circulating progenitors to either vessel type
is extremely infrequent. Rather, our results suggest that the vas-
cular malformations caused by Syk deficiency have an entirely
nonendothelial cell-autonomous basis.
In full agreement with this finding, we identified, characterized,
and isolated a population of Syk-expressing, myeloid cells that
had the capacity to signal lymphatic vessel growth. In semisolid
cultures, these cells failed to divide, indicative of mature, non-
proliferating leukocytes. Morphologically, a large fraction of the
Syk-expressing cells from skin appeared to belong to the mono-
cyte/macrophages lineage, and a surface marker analysis was
compatible, with more than three-fourths of these cells being
TEMs. The presence of marker-negative cells is likely due to
more immature cells within this embryonic population.Inc.
Figure 5. Macrophages Constitute the Majority of Leukocytes in the Developing Skin
(A–D) Single-cell suspensions from skin and fetal liver of embryos heterozygous (KI) or homozygous (KO) for Syk-CreD and homozygous for the R26R-reporter
allele (YFP) at (A) Day E13.0 or (B) Day E14.5 of development were immunostained for the indicated markers. YFP+ cells were analyzed by flow cytometry (see also
Figure S4); error bars represent the SD of three experiments. May-Gru¨nwald-Giemsa staining of cytospins from YFP+ (C) KI or (D) KO skin cells. Error bars repre-
sent the standard deviation of ten view fields.
(E and F) The frequency of large, highly vacuolated (type I) and small cells with a compact cytoplasm (type II, typical monocyte/macrophage appearance) was
enumerated. Error bars represent the standard deviation of ten view fields.
(G and H) Cytodex beads coated with VEGFR-2+/3+ mouse endothelium were cocultured with the YFP+ cells derived from 1 skin or 60,000 fetal liver cells.
The number and length of sprouts were measured after (G) 48 or (H) 72 hr.
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sidered to promote tissue remodeling, wound healing, and
angiogenesis, which is compatible with our finding that Syk+
tissue-resident myeloid cells express EphB4, FGF-2, MMP2/9,
PDGF-B, and VEGF-C/-D. Surprisingly, VEGF-A was only mar-
ginally upregulated in this population. This expression profile,Develowhich was even more pronounced in Syk/ cells, was charac-
teristic for cells isolated from skin, but not from fetal liver,
suggesting that extravasation is associated with differentia-
tion and adoption of the proangiogenic M2 phenotype.
We observed a concomitant downregulation of the M1 proin-
flammatory marker myeloperoxidase. Despite a slight increasepmental Cell 18, 437–449, March 16, 2010 ª2010 Elsevier Inc. 443
Figure 6. Protein and RNA Expression in Skin or YFP+ Cells Isolated from Skin and Fetal Liver
(A) Skin was dissected from wild-type and Syk/ embryos at the indicated times and lysed, and the listed antigens were measured by multiplexed enzyme-linked
immunosorbent assay (ELISA).
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ciated markers like Mrc1 (CD206), TLR4, and Lyve1, the Syk/
population also strongly upregulated the M1-associated chemo-
kine MCP-1/CCL2 and even expressed the corresponding
receptor, CCR2. These data indicate an aberrant differentiation
of peripheral macrophages in the absence of Syk. In myeloid
cells, Syk acts downstream of receptors/adapters that sig-
nal via ITAM motifs. Interestingly, the ITAM-bearing adaptor
DAP12 and FcRg have been shown to mediate inhibitory
responses in mononuclear myeloid cells, resulting in a reduced
inflammatory cytokine production and response to TLR stimula-
tion (reviewed in Turnbull and Colonna, 2007). We showed that
the build up of chemotractants in Syk/ skin results in increased
transendothelial migration of fetal liver cells. In addition to the
CCL2-CCR2 axis, increased levels of Ang2, which acts as
a monocyte chemotractant, might contribute to this effect.
Together with the enhanced expression of prolymphangiogenic
factors on a per cell basis, the growth factor profile and the accu-
mulation of Syk/ myeloid cells in the developing skin provide
the basis for the observed lymphatic hyperplasia, as we demon-
strated in a sprouting assay. Upon transplantation of equal
numbers of cells from Syk/ and control skin, indeed, both pop-
ulations displayed a lymphangiogenic activity in an adult dorsal
skin chamber, arguing that Syk+ myeloid cells do have the
potential to act on lymph vessels. However, in a physiological
environment, their activity and number are closely controlled.
As some of the factors produced by these cells also act on blood
vessels, they may, in addition, be responsible for the observed
alterations in blood vessel morphology.
In inflammatory processes and during tumor formation,
myeloid cells have been identified as sources of vascular growth
factors, including VEGF-C and -D (Schoppmann et al., 2002;
Baluk et al., 2005). However, during embryonic development,
leukocytes have so far not been described as instructive for
lymphatic vessel growth. VEGF-D was shown to fulfill regulatory
functions during lymphatic sprouting in Xenopus tadpoles
(Ny et al., 2008). In the mouse, it is dispensable for embryogen-
esis (Baldwin et al., 2005), and a developmental function remains
to be identified. Developmental VEGF-C overexpression from
the K14 or Tie-2 promotor, despite efficient induction of lymph
hyperplasia, is not sufficient to induce blood-lymphatic shunting.
Therefore, the combination of lymph-angiogenically active sub-
stances produced by myeloid cells, possibly including factors
not yet identified in our analysis, may be an important factor in
the induction of blood-lymphatic shunt formation.
Recently, a podoplanin (pdpn)-specific receptor on platelets,
CLEC-2, has been demonstrated to trigger platelet aggregation
in a Syk-Slp76-PLCg-dependent fashion (Suzuki-Inoue et al.,
2006, 2007). It has been suggested that pdpn-mediated CLEC-2
binding might act as a safeguard against blood-lymphatic(B) Identical analysis of isolated YFP+ cells from skin and fetal liver at E13.5. Diag
threshold of 2.53 the control sample level.
(C–H) Poly A+ RNA was isolated from (C) fetal liver or (D) skin and YFP+ cells isolate
the indicated genes was determined by quantitative PCR. YFP+ cells were homozy
Syk-CreD. Diagrams show the (C–F) fold change in KO over control samples or th
indicate a 95% confidence interval. Gray areas indicate a threshold of 23 the co
(I) Differences in the relative expression of CCR-2 between skin and fetal liver of
(J) Migration of 500,000 wild-type (WT) or KO fetal liver cells through a monolayer
migrated cells were counted after 7 hr. Error bars represent the standard deviati
Develomisconnections (Fu et al., 2008). This mechanism would also
be defective in Syk/ mice, which may contribute to their
inability to resolve blood-lymphatic shunts. However, Syk defi-
ciency causes much faster and more severe blood-lymphatic
alterations compared to those seen in pdpn/ mice, which
survive to birth and succumb as newborns from respiratory
failure (Ramirez et al., 2003; Schacht et al., 2003).
In summary, we propose that, in Syk/ embryos, deregulated
myeloid cells, which are largely comprised of TEMs, cause
a lymphatic hyperplasia, which leads to direct contact of BECs
and LECs and ultimately to the formation of blood-lymphatic
endothelial junctions (Figure S7). In mouse models that develop
blood-lymphatic connections after birth or during adult life,
vascular alterations often originate from the small intestine or
Peyer’s patches (Kiefer et al., 1998; Abtahian et al., 2003) and
may there be triggered by local inflammation and lymph vessel
activation. Such limited connections might be resolved by
pdpn-triggered platelet activation, which provides a possible
explanation for why small amounts of wild-type bone marrow
can rescue Syk deficiency in bone-marrow chimeras.
Our results have demonstrated the prolymphangiogenic
potential of Syk-expressing myeloid cells, and it will be an inter-
esting challenge to determine their physiological function during
development.
EXPERIMENTAL PROCEDURES
Generation of Syk-Creneo and Syk-CreD ‘‘Knockin’’ Mice
All animal experiments were approved by the Animal Experimentation
Committee of the county of Mu¨nster and the Federal Ministry of Nature, Envi-
ronment and Consumer Protection, North Rhine Westphalia.
Cre recombinase was placed under control of the Syk-regulatory elements.
Genomic Syk sequences were obtained from a PAC library (MRC geneservice
UK, RPCI21-501). The targeting construct was assembled employing modified
Red/ET recombination (Zhang et al., 2000) by using additional positive selec-
tion. For selection in embryonic stem (ES) cells, an FRT-flanked Pgk neomycin
(Pgk-neo) selection cassette was included. The targeting construct was elec-
troporated into R1 (129/Sv 3 129/SvJ) ES cells, and G418-resistant colonies
were analyzed by Southern blotting. Injection into C57BL/6 blastocysts
resulted in chimeric mice that were backcrossed to C57BL/6 to establish the
Syk-Creneo line.
The neomycin cassette was removed by crossing with transgenic Pgk-FLPe
mice. Successful deletion was verified by Southern blot and PCR (50-ATG
AATGCCACCGAGGAAG-30 [forward], 50-GAAGAACGAGATCAGCAGC-30
[Syk-Creneo reverse], and 50-CCTGATGAGGTTCTCCTTC-30 [Syk-CreD
reverse]). The resulting Syk-CreD strain was maintained on a C57BL/6 back-
ground. Syk-Creneo andSyk-CreD mice were crossed withR26R-lacZ (Soriano,
1999) and R26R-YFP (Srinivas et al., 2001) reporter strains, respectively.
Beta-Galactosidase Staining
Embryos at E9.5–E14.5 were dissected and rinsed in PBS. Yolk sac was
removed, and embryos were fixed in 2% PFA, 2 mM MgCl2, 2 mM
EGTA for 1–3 hr; washed in PBS; and stained for lacZ (0.1% 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6,rams show the fold change in Syk/ over control samples. Gray areas show
d from (E) fetal liver or (F) skin. After reverse transcription, relative expression of
gous for theR26R reporter and heterozygous (Control) or homozygous (KO) for
e (G and H) fold change in YFP+ skin over YFP+ fetal liver cells. (C–H) Error bars
ntrol sample level.
heterozygous Syk-CreD (KI) or (KO) embryos.
of bend5 endothelioma cells toward lysates from wild-type and KO skin. Trans-
on of triplet samples. One representative experiment of three is shown.
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Figure 7. Myeloid Cells from Embryonic
Skin Induce Lymph Vessel Activation and
Can Be Neutralized by VEGF-C/-D Blockade
(A–F) A total of 105 YFP+ cells from E14.5 fetuses
were embedded into a small fibrin clot and trans-
planted into a dorsal skin fold chamber. After
7 days, the skin underneath the implant was
dissected, the superficial connective tissue
including the YFP+ graft was removed, and blood
(isolectin B4, red) and lymph vessels (Lyve1,
green) were immunostained (see also Figure S5).
Tissue origin and genotype of the transplanted
cells are indicated. Skins transplanted with KI-
derived YFP+ fetal liver cells and fibrin controls
displayed no activation (identical to [A]) and are
not shown. Small panels show the details of the
lymph vessels. Scale bars in (A)–(F) represent
100 mm.
(G–I) Lymphatic sprouts. Scale bars in (G)–(I)
represent 20 mm.
(J) Lymphatic vessel area density and the number
of lymphatic sprouts underneath the transplant
are shown. Numerical values are means ± SEM.
The significance of the indicated data pairs
was determined by a Welch’s t test: *p < 0.05;
**p < 0.01; ***p < 0.001 (see also Table S1).
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37C. Stained embryos were washed in PBS, postfixed in 4% PFA for 4 hr,
and cleared by incubation in increasing glycerol concentrations.
Immunostaining
Skins were dissected, fixed in 4% PFA at 4C, permeabilized, and blocked in
PermBlock (1% BSA, 0.5% Tween 20). BECs were identified by endomucin
(7C7.1, generously provided by D. Vestweber) or Isolectin B4 (Invitrogen,
I32450) staining. LECs were stained with rabbit anti-Lyve-1 (ReliaTech,
103-PABi50), rat anti-Lyve-1 (R&D Systems, MAB2125), or rabbit anti-Prox-1
(ReliaTech, 102-PA30) antibodies. YFP detection was enhanced by staining
with rabbit anti-GFP antibodies (abCam, ab6556). Secondary antibodies
were Alexa dye coupled (Invitrogen). Tissues were mounted with Mowiol (Cal-
biochem, 475904) and analyzed with a Zeiss LSM-510META confocal micro-
scope (objectives: 203/0.8 Plan-Apochromat, 633/1.4 Oil Plan-Apochromat
[Carl Zeiss]). Where indicated, stacks were processed by using the IMARIS
software (Bitplane, Version 6.1.5).
Tissue Disaggregation, Cell Sorting, and Flow Cytometric Analysis
Fetal liver was removed and homogenized by passage through a 50 mm cell
strainer (Partec CellTrics 50 mm). The resulting single cells were suspended
in DMEM (GIBCO 31053). Embryonic skins were dissected and disaggregated
by Collagenase/Dispase (Roche 269638) digestion. YFP+ cells were isolated
with a FACSAria cell sorter (Becton, Dickinson and Company [BD]).
For flow cytometric analysis, single-cell suspensions were immunostained
with the antibodies listed in Figure S6B and then analyzed with a FACSCanto
flow cytometer (BD).
Colony-Forming Cell Assay for Hematopoietic Progenitor Cells
YFP+ cells from embryonic skin and fetal liver were plated in 35 mm bacterial
dishes at concentrations of 1.253 104 to 53 104 cells per milliliter of modified
IMDM (GIBCO, 42200-014) containing 1% (w/v) methylcellulose (Shin-Etsu-
Chemical), 10% heat-inactivated FBS (PAA; A15-043), 5% deionized and
delipidated BSA, 1.5% X63-Ag-653 cell-conditioned medium, 200 mg/ml
iron-saturated transferrin (Sigma), 25 mg/ml dipalmitoyl choline, cholesterol
and oleic acid (Sigma), 5U/ml Epo (Janssen Cilag), 10 mg/ml rh insulin (Sigma,
I9278), 12.5 ng/ml rmSCF (Cell Systems, CS-020275), 10 ng/ml rh IL-6 (Cell
Systems, CS-020213), 104 M b-mercaptoethanol (Sigma), and 15% 5637
cell-conditioned medium.
After 10 days, colonies consisting of >50 cells were counted and classified.
Correct designation was confirmed by pan-chromatic staining of cytospin
preparations.
Cytokine Profiling by Multiplexed ELISA
Skins were dissected, directly minced by using an Ultra-turrax tissue homog-
enizer, lysed in a detergent-free low-salt buffer (50 mM Tris-HCl, 2 mM EDTA
[pH 7.4]), and directly frozen in liquid nitrogen. Multiplexed immunoassay anal-
ysis of a panel of 58 antigens (RodentMAP,v. 2.0) was performed at RulesBa-
sedMedicine (Austin, Texas, USA).
RNA Isolation, cDNA Synthesis, and Quantitative Real-Time PCR
Total RNA was isolated from tissue homogenized in phenol/guanidinium-iso-
thiocyanat buffer (PEQLAB Biotechnologie GmbH). First-strand cDNA was
synthesized by using SuperScript III Reverse Transcriptase (Invitrogen),
primed by random hexamers (Applied Biosystems). Transcript levels were
determined by quantitative real-time PCR (qPCR) using corresponding Taq-
Man gene expression assays (Applied Biosystems) on a 7300 RT-PCR System
(Applied Biosystems).
Assessment of Angiogenic Activity In Vivo
The activity of YFP+ cells was tested in a mouse dorsal skin fold chamber.
Chambers were applied as described (Lehr et al., 1993); after 72 hr, chambers
were inspected for signs of surgical trauma or inflammation. YFP+ cells
were embedded in 0.5 mg/ml fibrinogen in DMEM activated by 1U thrombin.
Mice in the fibrin group received fibrinogen without cells. Where indicated,
10 mg VEGFR3-Fc (R&D systems) or 1 mg recombinant VEGF-C (ReliaTech,
Braunschweig) were administered together with fibrinogen. Mice were sacri-
ficed after 7 days. After removal of the superficial connective tissue, immunos-Develotaining and analysis were performed as described above. VEGFR-3-express-
ing mouse endothelial cells were a generous gift from R. Adams. Vessel area
density, representing the fraction of total tissue area occupied by vessel wall
or lumen and reflecting the overall number and size of vessels, was measured
by overlaying the microscopic image with a square lattice. The number of
lattice points intersecting the vessels was scored. Vessel area density was ex-
pressed as the fraction of points that intersect vessels.
Statistics
Statistical analysis was performed by using Sigma-Plot (Jandel Scientific).
The Welch Two-Sample t test was used to generate p values. Error bars repre-
sent standard error of the mean (SEM) (*p < 0.05; **p < 0.01; ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, Supplemental
Experimental Procedures, and two movies and can be found with this article
online at doi:10.1016/j.devcel.2010.01.009.
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